<?xml version="1.0" encoding="UTF-8"?>
<p id="para0005">The majority of HCV burden lies in low-middle income countries (LMIC), and two studies in this issue examine what is required to achieve HCV elimination in LMIC settings. In 2019, Mexico became the first country in Latin America to commit to HCV elimination, with the study by Marquez and colleagues finding that even in a setting where 95% of PWID have a history of HCV infection (i.e., antibody positive) and harm reduction is minimal, HCV elimination is possible through an intensive combination prevention scale-up approach,(
 <xref rid="bib0008" ref-type="bibr">Marquez etÂ al., 2020</xref>). Unfortunately, their modeling also shows that current government funding of compulsory abstinence programs could hamper these efforts, highlighting the need for scale-up of evidence based OST.
</p>
